Interleukin-23 Antagonist [EPC]: Side Effects & Safety Data for 5 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Interleukin-23 Antagonist [EPC] includes 5 drugs with a combined 116,871 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
5
Drugs in Class
116,871
Combined Reports
All Interleukin-23 Antagonist [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| USTEKINUMAB | PYZCHIVA | 85,332 | 4,519 | 17,127 | 5.3% |
| GUSELKUMAB | TREMFYA | 27,987 | 364 | 2,031 | 1.3% |
| RISANKIZUMAB | Skyrizi | 2,642 | 41 | 439 | 1.6% |
| TILDRAKIZUMAB | ILUMYA | 869 | 89 | 389 | 10.2% |
| MIRIKIZUMAB | Omvoh | 41 | 3 | 13 | 7.3% |
Common Side Effects in Interleukin-23 Antagonist [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Product dose omission issue | 18,725 | 14 |
| Drug ineffective | 14,698 | 1,002 |
| Off label use | 12,303 | 1,404 |
| Psoriasis | 6,947 | 370 |
| Fatigue | 5,853 | 1,494 |
| Arthralgia | 5,423 | 1,334 |
| Pain | 5,385 | 1,348 |
| Product use issue | 5,270 | 730 |
| Rash | 5,262 | 1,503 |
| Condition aggravated | 4,949 | 1,225 |